Europe Active Pharmaceutical Ingredients (API) Market 2021-2027


Posted April 1, 2021 by akash1143

Europe active pharmaceutical ingredients (API) market accounted for $45.77 billion in 2020 and will grow by 7.5% annually over 2020-2027 the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.

 
Europe active pharmaceutical ingredients (API) market accounted for $45.77 billion in 2020 and will grow by 7.5% annually over 2020-2027 the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.
Highlighted with 100 tables and 69 figures, this 167-page report “Europe Active Pharmaceutical Ingredients (API) Market 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.
Request Free Sample Report Aortic Repair Devices Industry Outlook, Click Here:
https://axelreports.com/request-sample/105874

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
Based on Synthesis, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.

synthetic API
• Branded Synthetic API
• Generic Synthetic API

Biotech API by Drug Type:
• Monoclonal Antibodies
• Recombinant Proteins
• Vaccines
• Other Biotech APIs

Biotech API by Customer Base:
• Innovative Biologic API
• Generic Biosimilar API

Biotech API by Expression Technology:
• Mammalian Expression
• Microbial Expression
• Yeast Expression
• Insect Expression
• Other Expression Technologies
HPAPI
• Branded HPAPI
• Generic HPAPI

Based on Manufacturing Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.

Captive Manufacturing
• Branded Captive API
• Generic Captive API

Merchant Manufacturing by Drug Type:
• Branded Merchant API
• Generic Merchant API

Merchant Manufacturing by Drug Synthesis:
• Merchant Synthetic API
• Merchant Biotech API

Based on Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications

Based on Drug Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs

Geographically, the following national/local markets are fully investigated:

• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Turkey, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue are available for 2017-2027. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.

Key Players (this may not be a complete list and extra companies can be added upon request):
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

Feel Free to Inquiry about this report:
https://axelreports.com/request-customization/105874


About Axel Reports:
Axel Reports is committed to being the key player in your company, offering you detailed information on products, market trends, competitors and customers. We offer premium progressive statistical surveys, market research reports, analysis and forecast data for industries and governments around the world. By allowing you to make well-informed choices, Axel Reports will help you develop a great successful marketing project. Axel Reports understands how crucial statistical tracking information is for any association or organization. Therefore, we have partnered with leading publishers and research companies specializing in specific domains, ensuring that you will receive the most reliable and up-to-date research data available.

Contact Us:
US Office:

30 BEAVER ST. WORCESTER, MASSACHUSETTS 01603, UNITED STATES

India Office:

Office No. P-221, Marvel Sangria Boulevard N.I.B.M. Road Pune -411060 India
+18488639402
[email protected]
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By axel reports
Phone 08488639402
Business Address India Office
Office No. P-221, Marvel Sangria Boulevard N.I.B.M. Road Pune -411060 India
Country India
Categories Fitness , Health , Industry
Tags active pharmaceutical ingredients , captive , merchant , growth opportunity , synthesis , synthetic , biotech , hpapi , trend forecast
Last Updated April 1, 2021